secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2022-05-16T23:59:59+00:00
Accession:  0001564590-22-020412
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ra Medical Systems reports Q1 loss of $5.5M, CFO Andrew Jackson resigns
-----------------------------------------------------------------------

- Revenue of $9,000 in Q1 2022, up from $4,000 in Q1 2021; minimal product sales.
- Loss from continuing operations $5.5M ($0.27 per share) vs $6.9M ($2.36) a year ago.
- CFO Andrew Jackson to resign effective May 25, 2022; resignation not due to any disagreement.
- Enrolled 107 of 125 subjects in pivotal atherectomy trial; filed 510(k) for next-gen DABRA 2.0 catheter.
- Completed public offering for ~$9.7M net proceeds; engaged investment bank to review strategic alternatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000156459022020412/0001564590-22-020412-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000156459022020412/rmed-8k_20220510.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-020412

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer